A fixed rule set over this filing's XBRL figures and the number of high-severity risks found in it — no model judgement.
Not investment advice and not a price target: it scores the quarter's fundamentals, not the stock. Full methodology →
AI Takeaway
No financial data or filing text was provided for HBAN's 2026-Q2 10-Q, so no substantive analysis of results or performance can be generated for this period.
No data available for HBAN 2026-Q2 10-Q — financial figures and filing text were not provided.
Last 4 quarters: 3 beats, 1 miss
Reported EPS of $0.39 versus the $0.38 analyst consensus — a +3.9% beat for Jun 2026.
The Filing Text Sections for this reporting period were marked as unavailable, so no Management's Discussion & Analysis content could be extracted. No income statement, balance sheet, cash flow, or ratio data was provided in the XBRL data either, preventing derivation of MD&A points from financial data.
Source: 10-Q Item 2 MD&A
No Risk Factors text or financial data (income statement, balance sheet, cash flow, ratios) was supplied for HBAN's 2026-Q2 10-Q. As a result, no company-specific risks can be identified or grounded in filing content for this period.
Source: 10-Q (no data provided)
This analysis does not extract a guidance section. Companies issue revenue and EPS outlook in the 8-K press release and on the earnings call rather than in the 10-Q itself — though the filing's management discussion can contain forward-looking statements, which appear in the highlights above where they were material.
Huntington Bancshares (HBAN) is next expected to report on , when the following quarter's results and any updated outlook will be available.
See the HBAN earnings preview — expected date, analyst estimates and what to watch →
Reported EPS of $0.39 versus the $0.38 analyst consensus — a +3.9% beat for Q2 2026.
No MD&A text, income statement, balance sheet, or cash flow data was available in the provided materials for this period. As a result, no specific takeaways can be summarized; the official 10-Q filing should be consulted directly.
Revenue figures were not provided in the data available for this analysis, so year-over-year revenue growth for HBAN's 2026-Q2 cannot be assessed. Please refer to HBAN's official 10-Q filing for reported revenue figures.
No balance sheet or ratio data (such as current ratio, debt-to-equity, ROE, or ROA) was provided for this period, so an assessment of HBAN's financial health cannot be made from the available information. The full 10-Q filing would need to be reviewed for these details.
No Risk Factors text was provided for this filing period, so specific company-disclosed risks cannot be cited. Investors should review the Risk Factors section of HBAN's actual 10-Q filing for this information.
Huntington Bancshares (HBAN) is next expected to report earnings on Oct 22, 2026. The date comes from the analyst earnings calendar and can shift until the company confirms it.
Expected release date, analyst estimates & what to watch
Huntington Bancshares (HBAN) reported Q1 FY2026 results showing strong revenue growth of 34.5% YoY to $472M, while net income slipped slightly to $523M and EPS declined 23.5% to $0.26, reflecting the impact of a significantly expanded balance sheet following what appears to be a major acquisition.
Huntington Bancshares (HBAN) delivered strong FY2025 results with net income rising 14.0% to $2.21B, operating cash flow surging 35.2% to $2.48B, and total assets expanding 10.2% to $225.1B, reflecting solid balance sheet growth and improved profitability.
Other companies in Regional Banks